STOCK TITAN

NOVONIX (ASX: NVX) lapses 5.78M performance rights and updates capital

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

NOVONIX Limited reported a change to its share capital after certain employee-style awards lapsed. On 30 June 2026, a total of 5,781,507 NVXAD PERFORMANCE RIGHTS ceased due to the lapse of conditional rights where vesting conditions were not, or could not be, satisfied. The company confirmed it paid no consideration for this cessation.

After this change, NOVONIX’s issued capital includes 991,561,920 NVX ordinary fully paid shares on issue and unquoted equity securities such as 21,619,875 NVXAD performance rights, 14,016,667 NVXAA options, 1,371,566 NVXAB share rights and 45,221,586 NVXAL convertible notes.

Positive

  • None.

Negative

  • None.
Performance rights lapsed 5,781,507 NVXAD performance rights Ceased on 30/06/2026 due to unmet conditions
Ordinary shares on issue 991,561,920 NVX ordinary fully paid Quoted equity securities after cessation
Remaining performance rights 21,619,875 NVXAD performance rights Unquoted equity securities on issue
Options on issue 14,016,667 NVXAA options Unquoted, expiring various dates at various prices
Share rights on issue 1,371,566 NVXAB share rights Unquoted equity securities
Convertible notes on issue 45,221,586 NVXAL convertible notes Unquoted equity-linked securities
Cessation consideration No consideration paid For lapse of 5,781,507 performance rights
PERFORMANCE RIGHTS financial
"NVXAD PERFORMANCE RIGHTS 5,781,507 Lapse of conditional right to securities"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
lapse of conditional right to securities financial
"Lapse of conditional right to securities because the conditions have not been, or have become incapable"
issued capital financial
"We (the entity named above) provide the following information about our issued capital."
convertible notes financial
"NVXAL CONVERTIBLE NOTES 45,221,586"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
unquoted equity securities financial
"Unquoted +equity securities that have ceased Number of securities that have ceased"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of June, 2026

 

 

001-41208

 

 

(Commission File Number)

 

 

NOVONIX LIMITED

(Translation of registrant’s name into English)

 

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 


EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

Exhibit 99.1

 

Appendix 3H (Notification of cessation of securities) dated June 30, 2026

 

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED

 

 

By:

/s/ Robert Long

 

Robert Long

 

Chief Financial Officer

 

Date: June 30, 2026

 

 


 

img58969013_0.jpg

 

Appendix 3H - Notification of cessation of securities

 

 

EXHIBIT 99.1

Announcement Summary

 

 

Entity name

NOVONIX LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday June 30, 2026

 

Details of +securities that have ceased

 

 

 

 

Number of

 

 

 

ASX +security

 

+securities that

The +securities have

Date of

 

code

Security description

have ceased

ceased due to

cessation

 

 

NVXAD

PERFORMANCE RIGHTS

5,781,507

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

 

30/06/2026

 

Refer to next page for full details of the announcement

 

 

Appendix 3H - Notification of cessation of securities

1 / 4

 


 

img58969013_0.jpg

 

Appendix 3H - Notification of cessation of securities

 

 

Part 1 - Announcement Details

 

 

 

1.1 Name of +Entity

NOVONIX LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type

Registration Number

ABN

54157690830

 

 

 

 

1.3 ASX issuer code

NVX

 

 

 

1.4 The announcement is

New announcement

 

1.5 Date of this announcement

30/6/2026

 

 

 

 

 

Appendix 3H - Notification of cessation of securities

2 / 4

 


 

img58969013_0.jpg

 

Appendix 3H - Notification of cessation of securities

 

 

Part 2 - Details of +equity securities or +debt securities that have ceased

 

 

ASX +Security Code and Description

NVXAD : PERFORMANCE RIGHTS

 

Unquoted +equity securities that have ceased Number of securities that have ceased

5,781,507

 

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation

Is the entity paying any consideration for the cessation?

30/6/2026

No

 

 

Any other information the entity wishes to notify to ASX about the cessation?

 

Performance rights forfeited on cessation of employment.

 

 

 

Appendix 3H - Notification of cessation of securities

3 / 4

 


 

img58969013_0.jpg

 

Appendix 3H - Notification of cessation of securities

 

 

Part 3 - Issued capital following changes

 

 

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

 

ASX +security code and description

Total number of

+securities on issue

 

 

NVX : ORDINARY FULLY PAID

991,561,920

 

 

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

 

ASX +security code and description

Total number of

+securities on issue

 

 

NVXAD : PERFORMANCE RIGHTS

21,619,875

 

 

NVXAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

14,016,667

 

 

NVXAB : SHARE RIGHTS

1,371,566

 

 

NVXAL : CONVERTIBLE NOTES

45,221,586

 

 

 

NVXAH : CONVERTIBLE DEBENTURES

35,000,000

 

 

 

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

 

 

Appendix 3H - Notification of cessation of securities

4 / 4

 


FAQ

What change to NOVONIX (NVX) securities was announced in June 2026?

NOVONIX reported the cessation of 5,781,507 NVXAD PERFORMANCE RIGHTS on 30 June 2026. These rights lapsed because their conditions were not met or became incapable of being satisfied, reducing the pool of outstanding performance rights.

Why did 5,781,507 NOVONIX NVXAD performance rights lapse?

The 5,781,507 NVXAD PERFORMANCE RIGHTS lapsed due to a "lapse of conditional right to securities". The filing states the conditions attached to these rights were not met, or became incapable of being satisfied, so the rights ceased under their original terms.

Did NOVONIX pay any consideration for the cessation of these performance rights?

No, NOVONIX stated it is not paying any consideration for the cessation of the 5,781,507 NVXAD performance rights. This means the rights simply lapsed under their conditions, without any cash or other compensation being paid by the company.

What is NOVONIX’s ordinary share count after the June 2026 changes?

Following the cessation of certain performance rights, NOVONIX reported 991,561,920 NVX ordinary fully paid shares on issue. This figure reflects the company’s quoted ordinary equity securities used by the ASX to help calculate NOVONIX’s market capitalisation.

How many NOVONIX performance rights remain on issue after the lapse?

After the lapse of 5,781,507 NVXAD performance rights, NOVONIX reported 21,619,875 NVXAD PERFORMANCE RIGHTS on issue. These remaining rights are unquoted equity securities and are separate from the company’s quoted ordinary fully paid shares on the ASX.

What other unquoted NOVONIX securities are currently on issue?

NOVONIX lists several unquoted securities: 21,619,875 NVXAD performance rights, 14,016,667 NVXAA options, 1,371,566 NVXAB share rights and 45,221,586 NVXAL convertible notes. These instruments sit alongside the company’s 991,561,920 quoted ordinary shares on the ASX.

Filing Exhibits & Attachments

1 document